Home - Marketaccess & Pricingstrategy

Healthcare Market Access 4.0

The AI-Based Global Market Access Planning Tool

mAxInsights® is your AI based tool that makes it easy for healthcare companies to enter new markets quickly & effectively. It offers a fast, reliable and affordable market access planning platform with:

Quick clinical assessment
Reimbursement codes & epidemiology
Reimbursement process per country

mAxInsights® can be accessed by startups, accelerators as well as established companies and is currently available for Europe and the United States of America. Further countries in Europe and North America are being implemented in the course of 2024.

Unlock efficiency. Fast-track your dossier writing.

DO-Bo is the pioneering artificial intelligence medical writing bot, developed exclusively to enhance and expedite the creation of reimbursement dossiers.

In healthcare reimbursement processes, comprehensive and compliant dossiers are crucial. Though, their development and writing is time-consuming and resource-intensive.

Powered by advanced artificial intelligence and a unique closed language model, DO-Bo is specifically tailored for the nuanced field of healthcare reimbursement.

With DO-Bo, dossier versions for the US (AMCP), Europe (EU joint HTA), and Germany (AMNOG) are available within minutes after upload of all relevant materials and documents in the secured and closed back-end.

With DO-Bo, dossier development is moving into a new era – focusing on the strategic input and review of dossiers!

Optimize your training with our AI-based technology to succeed in every sales pitch or negotiation

Q-BO is an AI-based platform designed to optimally prepare you for sales pitches and negotiations. Utilizing the latest learning concepts, such as exposure therapy, Q-BO enhances the results of your training to its maximal potential.

Users can safely upload training content to their selection and engage in individual learning sessions via text or audio. Train anywhere and anytime with Q-BO for maximum ﬂexibility and effectiveness.

Besides, you can assess your performance after every interaction with Q-BO. Whether it is via text or audio, Q-BO will give you a score for every single action you provide, and ultimately a final score for your entire performance. Q-BO trains and tests your knowledge thoroughly and makes you an expert on your subject!

Last but not least! Q-BO’s AI-based technology is the engine, brain, and source of the learning experience by Wafle, the VR-training technology of MArS.

Negotiate with confidence. AI based virtual reality training.

Wafle elevates your knowledge transfer in the era of Market Access 4.0

Our virtual reality (VR) and artificial intelligence (AI) platform offers a transformative approach to training, providing your team with immersive, interactive experiences. Engage in scenarios that mimic real-life interactions with healthcare professionals or payers, navigate complex compliance guidelines, and master the art of relationship building and sales strategies within a controlled, engaging virtual environment.

AI-driven analytics and user input ensure each session is tailored to the individual’s learning path, accelerating proficiency and confidence across compliance, key accounts, and sales disciplines.

Empower your team with the skills to excel and lead in the healthcare industry through our advanced VR and AI training platform Wafle.

Moolya-AI: Payer Intelligence for Smarter Market Access Decisions

In global pharmaceutical market access, pricing and reimbursement decisions are only as good as the intelligence that informs them. Yet gathering structured, evidence-based insights on payer expectations, willingness-to-pay thresholds, and competitive reimbursement landscapes remains one of the most resource-intensive and fragmented challenges in launch preparation.

Moolya-AI was built to solve exactly this problem.

Evidence with real-world data (RWD): precise and fast

Gain solid insights from real-world healthcare data (RWD). It analysis enhances the impact of your research and provides a robust foundation for important healthcare decisions. RWD provides complex insights into the reality of healthcare. You can use RWD to close crucial knowledge gaps and drive innovation in your research. Yet, accessing and working with RWD can be challenging, requiring specialised expertise and a significant investment of time. Evin Hub brings this experience to the table, streamlining the research process to accelerate your results – from planning, analyzing to writing and publishing.

Rooted in D-A-CH. Delivering across Europe and North America.

MArS has grown from a highly specialised market access consultancy for Germany, Austria and Switzerland into an international partner supporting healthcare companies across Europe and North America.

Our D-A-CH expertise remains at the heart of who we are. It is complemented by international experience, local market expertise and a strong network of partners across key global markets.

We support pharmaceutical, medtech, diagnostic and digital health companies from early market access planning through evidence generation, reimbursement submissions, payer engagement and price negotiations.

The result: one experienced partner combining international perspective with the local market understanding needed to reduce uncertainty, accelerate access and achieve stronger reimbursement outcomes.